Introduction & Contents

Introduction

Over 8-10 June 2021, Antibody Engineering & Therapeutics Europe Virtual took place online with keynotes, training courses, panel discussions and hot topic roundtables presented by industry leaders and pioneers, live and on-demand.

In this post-event report, we take a look back at highlights from the week, including summaries of top keynotes and popular presentations by Candace Kastanis, and an exclusive presentation video and case study from AbCellera.

Whether you joined us for the event, or just want to see what the fuss was all about, we hope that like us, these highlights will get you excited for the upcoming hybrid Antibody Engineering & Therapeutics event in San Diego and online on December 12 - 16, 2021.

Jump to any article using the contents on the following page, or at any time using the Contents menu in the top left. There you can also download this report as a PDF.

Live Keynote Highlights

Sugar Switches of IgG in Human Immune Responses Affect the Outcome of COVID-19 with Gestur Vidarsson, Head of Immunoglobulin Research/PI, Experimental Immunohematology at Sanquin Research
Mechanisms of Antibody-mediated Resistance to Infectious Diseases with Antonio Lanzavecchia, Group Leader; SVP and Senior Research Fellow at National Institute of Molecular Genetics, INGM; Humabs BioMed
Advances in Bispecific, Soluble TCR Therapies with Bahija Jallal, Chief Executive Officer at Immunocore

Exclusive Whitepaper

Case Study: Amplifying Antibody Diversity

This case study by AbCellera demonstrates a discovery program to identify an antibody against a validated target, with 100% homology across mice, rats and humans.

Revisiting Top Presentations

Tackling COVID-19 with Human Neutralizing Antibodies with Davide Corti, SVP, Antibody Research at Humabs BioMed SA
An Adaptable Antibody-based Platform for Flexible Synthetic Peptide-based Cargo Delivery Based on Agonistic CD40-directed Antibodies with Sara Mangsbo, Senior Associate Lecturer at Uppsala University
Anti-CD38/CD28xCD3 Trispecific T cell Engager for the Treatment of Multiple Myeloma with Nizar El-Murr, Principal Scientist and Lab Head - Immuno-Oncology Research at Sanofi

Watch on-demand

Amplifying Antibody Diversity: Single-Cell Screening Combined with Repertoire Sequencing from Humanized Mice

Watch this on-demand presentation by Kevin Heyries at AbCellera.